Myocarditis

In the top story in cardiology last week, researchers reported that most suspected cases of COVID-19 vaccine-related myocarditis were mild and resolved quickly in patients aged younger than 21 years.

Most young people under the age of 21 years with suspected myocarditis following COVID-19 vaccination had mild symptoms that resolved quickly, according to data published in Circulation.

The ability of COVID-19 to cause cardiac injury and myocarditis has been well documented since the pandemic began, and data continue to accumulate.

According to a new study, immune checkpoint inhibitor-induced myocarditis is highly associated with arrhythmias and ECG findings including new conduction blocks, decreased voltage and repolarization abnormalities.

According to Moderna, the FDA said it will need more time to review the company’s request for an emergency use authorization of its COVID-19 vaccine in adolescents to further review the risk for myocarditis in this population.

Healio and Cardiology Today have compiled a list of the most-read cardiology news of October 2021.

Data from two new studies revealed that the incidence of myocarditis was uncommon among patients after COVID-19 vaccination. It was the top story in cardiology last week.

In two studies from Israel published in The New England Journal of Medicine, incidence of myocarditis after COVID-19 vaccination remained low; however, almost all documented cases were in young men.

Acute myocarditis was rare in individuals who received at least one dose of the Pfizer-BioNTech or Moderna COVID-19 vaccine, according to findings published in JAMA Internal Medicine.

Healio and Cardiology Today have aggregated a list of the most-read news in cardiology of July 2021.